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Abstract
Objective: Body weight and overt thyroid dysfunction are associated. Cross-sectional population-based studies have
repeatedly found that thyroid hormone levels, even within the normal reference range, might be associated with body
weight. However, for longitudinal data, the association is less clear. Thus, we tested the association between serum
thyrotropin (TSH) and body weight in a community-based sample of adult persons followed for 11 years.
Methods: A random sample of 4,649 persons aged 18–65 years from a general population participated in the DanThyr study
in 1997–8. We included 2,102 individuals who participated at 11-year follow-up, without current or former treatment for
thyroid disease and with measurements of TSH and weight at both examinations. Multiple linear regression models were
used, stratified by sex and adjusted for age, smoking status, and leisure time physical activity.
Results: Baseline TSH concentration was not associated with change in weight (women, P = 0.17; men, P = 0.72), and
baseline body mass index (BMI) was not associated with change in TSH (women, P = 0.21; men, P = 0.85). Change in serum
TSH and change in weight were significantly associated in both sexes. Weight increased by 0.3 kg (95% confidence interval
[CI] 0.1, 0.4, P = 0.005) in women and 0.8 kg (95% CI 0.1, 1.4, P = 0.02) in men for every one unit TSH (mU/L) increase.
Conclusions: TSH levels were not a determinant of future weight changes, and BMI was not a determinant for TSH changes,
but an association between weight change and TSH change was present.
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Introduction
The thyroid gland produces thyroid hormones, which regulate
gene transcription and metabolism throughout the body. Thyroid
hormones play a key role in the basal metabolic rate, thermogen-
esis, as well as in the regulation of body metabolism in starved and
fed states [1–3]. Overt thyroid disease is associated with marked
changes in energy expenditure and body weight, with enhanced
protein breakdown, lipolysis [4,5], and typically weight loss in
hyperthyroidism, and the reverse in hypothyroidism [6]. More-
over, small changes in T4 dose in patients in long-term T4
treatment have been shown to modify resting energy expenditure
significantly [7].
The main role of adipose tissues is to store energy to meet the
energy needs of the body and to protect it from excess glucose by
converting this to and storing it as triglycerides. Recently, adipose
tissue has been recognized as a major endocrine organ, involved in
the regulation of thermogenesis, food intake, and energy
expenditure, e.g., the change between fed and starved state [3].
Studies of weight reduction by bariatric surgery [8] or gastric
banding [9] have found postoperative changes in levels of TSH
(serum thyrotropin), free T4 (thyroxine) and free T3 (triiodothy-
ronine), but in different directions. Likewise, a decrease in TSH
was observed following diet-, exercise-, and behavior therapy-
induced weight loss in children and adolescents [10,11].
Conversely, obesity induced by high-fat diet weight gain has a
significant effect on T4 and T3 levels in rats [12]. A relationship
between body weight and thyroid hormones seems conceivable.
The exact mechanisms are as yet unexplained and the temporality
is debated.
Evidence from several cross-sectional population-based studies
has shown a significant positive association between body mass
index (BMI) and serum TSH, even for values of TSH within the
normal reference range [13–18], among those a study by Knudsen
et al. on baseline data from this cohort [16]. However, the number
of longitudinal studies of the association are limited [14,17,19,20]
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and the results are conflicting. The aim of the present study was to
investigate the association between 11-year longitudinal changes in
thyroid function as assessed by serum TSH and changes in body
weight in a large sample of adult Danes. Furthermore, we wished
to test the hypothesis that the relationship between serum TSH
and free T4 is dependent on weight; a relation previous suggested
to be a useful measure of the abnormal thyroid hormone sensitivity
in a study of patients with hereditary pituitary resistance to thyroid
hormones [21].
Materials and Methods
Ethics Statement
Participants gave their written informed consent, and studies
were approved by the North Denmark Region Committee on
Health Research Ethics (Nos. 2-16-4-0001-97, VN 96/208mch,
and N-VN-19960208mch), and the Danish Data Protection
Agency. The recommendations of the Declaration of Helsinki
were followed.
Design and Population
The DanThyr program, described earlier in detail [22], is a
Danish program monitoring the presence and development of
thyroid disease before and after iodine fortification of household
salt and salt used in the commercial production of bread since 1st
July 2000. The present study used data from C1 cohort in the
DanThyr program initiated in 1997/98 (C1a, N= 4,649, 50.1%
participation) [23] and followed up in 2008–2010 (C1b, N= 2,465,
59.1% of baseline participants) [24]. The random samples were
drawn from Copenhagen in the eastern part of Denmark and
Aalborg in the western part of Denmark, representing areas with
pre-fortification mild and moderate iodine deficiency, respectively.
Using the national Civil Registration system, in which all
inhabitants of Denmark can be identified by a unique 10 digit
number, the sampling included four age groups of women (18–65
years) and one age group of men (60–65 years).
Participants underwent physical examination, gave a non-
fasting venous blood sample and a spot urine sample, and had a
thyroid ultrasonography (US) performed (Siemens Sonoline Versa
Pro, Siemens, Erlagen, Germany). All procedures (e.g., invitation,
questionnaires, and examination) were similar at baseline and
follow-up examination. Blood and urine samples were collected
between 08.00 a.m. and 5.30 p.m., stored at 220uC, and
subsequently analyzed in random order with respect to region,
sex, age, and season of the year at examination, at baseline, and
follow-up. The normal reference range was defined in the baseline
cohort as follows: TSH, 0.4–3.6 mU/L; free T4, 9.8–20.4 pmol/L
[23].
Among the 2,465 examined at both baseline and follow-up, 36
had missing serum TSH values, 28 had missing measurement of
weight, 86 persons were pregnant, 228 had current or former
treatment for thyroid disease (medicine, surgery, or radioactive
iodine therapy), leaving 2,102 participants for analysis (Figure 1).
Moreover, we replicated all analysis after exclusion of 282
participants with a baseline serum TSH concentration outside
the normal reference range (below 0.4 mU/L or above 3.6 mU/
L), leaving 1,944 participants for analysis. They were defined as
being euthyroid at baseline (shown in Figure 1). This was done to
increase comparability with related studies.
Analyses
LUMItest assays were used to measure TSH and free T4 at
baseline (BRAHMS, Berlin, Germany) and the Roche Modular
EH system by electrochemical luminescence using ELECSYSH
(Roche Diagnostics 6M6H, Mannheim, Germany) at follow-up.
The lower limit of detection was 0.01 mU/L at baseline and
0.014 mU/L at follow-up. The size of the bias induced by the
change in assay from baseline to follow-up was calculated in a
subsample of 201 blood samples. The Bland-Altman plot showed
very low inter-assay variation without marked irregularities (data
not shown). The bias for TSH was modest (mean difference:
0.019 mU/L, 95% confidence interval [CI] 20.25 to 0.29 mU/
L). Reanalysis of serum free T4 showed higher values when
analyzed with the follow-up assay (1.65 pmol/L, 1.30–2.00 pmol/
L). TPO-Ab measurements were analysed by radioimmunoassay
(RIA) technique by DYNOtest anti-TPO method (BRAHMS
Diagnostica, Berlin, Germany) at baseline, as described earlier
[25] and KRYPTOR anti-TPOn (BRAHMS Diagnostica, Berlin,
Germany), an automated antibody assays were used at follow-up
[26]. No difference in CV performance between the two assays
was found in a previous study [26]. Positive TPO-Ab status was
defined as 30 kU/liter or higher according to the functional
sensitivity given by the manufacturer and the limits used in
previous DanThyr studies [25]. Urine iodine concentrations were
determined at both examinations using the Ce/As method after
digestion by alkaline ashing, as previously described [27,28]. The
analytical sensitivity of the assay was 2 mg/L. The iodine
laboratory was certified by the U.S. Centers for Disease Control
and Prevention EQUIP program.
Variable Definition
BMI was calculated as weight (kg) divided by the square of
height (m2). Weight and height were measured when the
participants were wearing light clothes and no shoes. Treatment
with medicine, surgery, or radioactive iodine therapy for thyroid
disease, smoking status, and leisure time activity were self-
reported. Smoking was classified as: never smokers, former
smokers, occasional smokers, and daily smokers. According to
the 11-year change in smoking status, participants were classified
as: current smokers (N= 572), never smokers (N=949), former
smokers (N= 402), those who stopped smoking during follow-up
(N= 381), and those who started smoking during follow-up
(N= 98). A dichotomized smoking status (daily smoking, yes/no)
was used to test the interaction with smoking in the three models.
According to leisure time physical activity, participants were
classified as mainly sedentary; light physical activity, 2–4 hours a
week; light physical activity, more than 4 hours a week; or heavy
physical activity, more than 4 hours a week. Eleven-year changes
in physical activity were classified as less active, unchanged, or
more active.
Statistical Analysis
Data were analyzed using SAS, version 9.2 (SAS Institute Inc.
Cary, NC, USA). Two-sided probability values ,0.05 were
considered significant. Non-normally distributed variables were
log transformed to obtain a normal distribution. Descriptive
characteristics of the participants presented as percent (total) or
median (interquartile range, IQR) were compared with non-
parametric statistics, Kruskal-Wallis test. We used multiple linear
regression analysis to model the associations in the following three
models: 1) the association between baseline serum TSH and
change in weight during follow-up; 2) the association between
change in serum TSH and change in weight during follow-up; and
3) the association between baseline BMI and change in serum
TSH concentration during follow-up. Furthermore, we modeled
linear regressions of: 1) the association between baseline free T4
and change in weight during follow-up; and 2) the association
between change in free T4 and change in weight. Men and
Thyroid Function and Body Weight
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women were analyzed separately because of the age and sex
composition of the population. All the models were adjusted for
the baseline value of the outcome to adjust for regression to the
mean and to allow changes in the exposure variables to be
interpreted as effects on outcome changes from baseline to follow-
up [29]. In addition, we adjusted for age at baseline (categorical),
change in smoking status, and change in leisure time physical
activity. Because the age range was only 5 years for men, the age
variable was left out in their analysis. We also divided the exposure
variables in the above described regression models in quartiles to
test for a non-linear relationship between predictor and outcome.
In additional analysis, the relationship between D TSH (TSH
concentration at follow-up minus TSH concentration at baseline,
as outcome) and D free T4 concentration (as predictor) in three
weight change groups (tertiles) was evaluated by linear regression
analysis, adjusting for age group, change in smoking, and change
in leisure time physical activity (and for the baseline value of serum
TSH). We added an interaction term between D free T4 and
Figure 1. Flow chart of the study group. TSH serum thyrotropin.
doi:10.1371/journal.pone.0093515.g001
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weight change tertiles to test if the regression lines for the three
weight groups were significantly different. Slopes of the three
regression lines were identified from the same model. This analysis
was restricted to women.
We tested the validity of all linear models by checking normality
of residuals, homogeneity of residuals, and linearity of the
relationship between response variable and predictors.
Wilcoxon Rank test was used to compare the independent
measures of baseline characteristics of participants and non-
participants at the re-examination.
Results
Descriptive characteristics of the participants are shown in
Table 1. The average follow-up time was 11.2 years (range, 10.1–
12.8 years). Weight increased by 3.0 kg (95% CI, 2.7–3.3 kg)
during follow-up; weight did not change significantly in men, 60–
65 years at baseline (20.2 kg, 95% CI, 20.9–0.4 kg), whereas it
increased significantly by 3.7 kg (95% CI, 3.4–4.1 kg) in women
(18–65 years at baseline). The median serum TSH increased
significantly from the first to the second examination in the total
population of individuals (from 1.30 (95% CI, 0.91–1.89) to 1.44
(95% CI, 0.99–2.05), P,0.01), as well as among men (from 1.24
(95% CI, 0.83–1.82) to 1.40 (95% CI, 0.94–2.02), P,0.01) and
women (from 1.31 (95% CI, 0.92–1.90) to 1.45 (95% CI 1.00–
2.06), P,0.01).
The median serum TSH increased significantly from the first to
the second examination in the total population of individuals
(P,0.01), as well as among men (P,0.01) and women (P,0.01).
In the adjusted model, we found no association between
baseline log TSH and weight change during follow-up in either sex
among individuals without treatment for thyroid disease (women,
P= 0.17; men, P= 0.72) and in persons with a serum TSH within
the normal reference range at baseline (women, P= 0.19; men,
P= 0.06). No association between baseline log BMI (modeled as a
continuous variable) and TSH change was found, neither in all
non-treated persons (women, P= 0.21; men, P= 0.85) nor in those
with a baseline TSH concentration within the normal reference
range (women, P= 0.78; men, P= 0.69).
A significant association between change in serum TSH
concentrations and weight change was observed in both sexes
(Table 2). In the adjusted model, weight increased by 0.3 kg (95%
CI, 0.1–0.4) for every one-unit increment in serum TSH (mU/L)
(P= 0.005) in women free of thyroid disease. In men, a one-unit
increment in TSH was associated with a 0.8 kg (95% CI, 0.1–1.4,
P= 0.02) increase in body weight. In the group of participants who
had a baseline TSH within the normal reference range, weight
increased by 0.6 kg (95% CI, 0.4–0.9, P,0.01) for every unit
increment in serum TSH among women, and by 0.7 kg (95% CI,
0.02–1.3, P = 0.04) for every unit increment in TSH among men.
Women with a serum TSH change in the lowest quartile had a
mean weight increase of 1.2 kg (IQR 22.8, 5.4), whereas women
Table 1. Serum thyrotropin status and body mass index according to characteristics.
Baseline Follow-up
Characteristics All participants % (N) Median (IQR) Median (IQR)
Serum TSH
(mU/L) BMI (kg/m2)
Serum TSH
(mU/L) BMI (kg/m2)
Age (years) 18–20, women 19.7% (415) 1.42 (0.98, 1.98) 22.1 (20.4, 24.6) 1.46 (1.11, 2.00) 23.6 (21.2, 26.9)
25–30, women 20.8% (436) 1.36 (0.99, 1.92) 22.4 (20.6, 24.3) 1.49 (1.04, 2.09) 23.5 (21.5, 26.6)
40–45, women 26.9% (566) 1.23 (0.85, 1.78) 24.1 (21.9, 27.0) 1.42 (0.93, 2.07) 25.5 (23.0, 28.9)
60–65, women 13.6% (286) 1.31 (0.84, 1.96) 26.2 (23.9, 29.0) 1.40 (0.94, 2.11) 26.6 (24.1, 29.7)
60–65, men 19.0% (399) 1.24 (0.83, 1.82) 26.3 (24.6, 28.9) 1.40 (0.94, 2.02) 26.6 (24.9, 29.5)
P valuesa 0.0019 ,0.0001 0.39 ,0.0001
Leisure time physical activity Sedentary 11.4% (237) 1.22 (0.91, 1.92) 23.9 (21.5, 28.1) 1.40 (0.94, 2.09) 26.7 (22.9, 30.9)
Light 45.9% (956) 1.28 (0.90, 1.82) 24.5 (21.9, 27.4) 1.41 (0.98, 2.00) 25.5 (22.8, 28.9)
Moderate/vigorous 42.7% (889) 1.33 (0.92, 1.92) 23.9 (21.7, 26.3) 1.49 (1.02, 2.07) 24.8 (22.3, 27.3)
P valuea 0.34 0.009 0.24 ,0.0001
Smoking status Current smoker 32.3% (678) 1.21 (0.84, 1.76) 23.5 (21.2, 26.3) 1.22 (0.85, 1.78) 24.8 (22.1, 28.1)
Never smoker 40.2% (846) 1.35 (0.96, 1.99) 24.0 (21.4, 26.8) 1.56 (1.10, 2.16) 25.1 (22.4, 28.2)
Former smoker 19.6% (413) 1.30 (0.88, 1.97) 25.5 (23.2, 28.2) 1.43 (0.98, 2.08) 25.7 (23.3, 29.0)
Occational smoker 7.8% (165) 1.28 (0.82, 1.84) 23.8 (22.1, 27.0) 1.43 (1.00, 1.98) 24.7 (22.3, 28.4)
P valuea 0.0003 ,0.0001 ,0.0001 0.0002
Region Copenhagen 50.7% (1,065) 1.34 (0.92, 1.91) 24.1 (21.7, 27.1) 1.53 (1.06, 2.17) 25.0 (22.5, 28.2)
Aalborg 49.3% (1,037) 1.27 (0.87, 1.82) 24.1 (21.8, 26.8) 1.35 (0.90, 1.92) 25.5 (22.7, 28.6)
P valuea 0.03 0.68 ,0.0001 0.11
TPO-Ab status (kU/L) $30 21.1% (443) 1.42 (0.96, 2.12) 23.5 (21.7, 26.7) 1.78 (1.15, 2.80) 24.9 (22.8, 28.1)
,30 78.9% (1,655) 1.28 (0.89, 1.82) 24.3 (21.8, 27.1) 1.39 (0.96, 1.91) 25.3 (22.6, 28.5)
P valuea 0.0001 0.057 ,0.0001 0.52
aKruskal-Wallis test.
TSH serum thyrotropin, BMI body mass index, TPO-Ab thyroid peroxidase antibody, CI confidence interval, IQR interquartile range.
doi:10.1371/journal.pone.0093515.t001
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in the highest quartile of change in TSH had a weight increase of
3.6 kg (IQR 20.2, 7.4) (P for trend,0.0001).
In addition, all the regression analyses were repeated with the
predictor variable divided into quartiles, which showed essentially
unchanged estimates (data not shown). No significant interaction
with smoking status (yes/no) was found in any of the three models,
and no significant interaction with region (used as a proxy for
different levels of iodine intake) was observed in the regression of
the association between TSH change and change in weight during
follow-up (women, P for trend= 0.96; men, P for trend= 0.25).
Moreover, we did not find any association between natural
logarithm to creatinine-adjusted iodine excretion at baseline and
change in weight in an age-adjusted, sex-stratified multiple linear
regression model (data not shown).
We found no significant association between baseline free T4
level and weight change during 11-year follow-up among
individuals without treatment for thyroid disease (women,
P= 0.58; men, P= 0.42), and in persons with a TSH within the
normal range at baseline (women, P= 0.44; men, P= 0.36). An
inverse association was found between 11-year free T4 change and
weight change in non-treated women (20.21 kg change/(pmol/
liter change) (95% CI, 20.33–20.09), P = 0.008), but not
significant in men (20.16 kg change/(pmol/liter change) (95%
CI, 20.37–0.05), P = 0.14). In persons with a TSH within the
normal range at baseline similar results were found (women,
20.22 kg change/(pmol/liter change) (95% CI, 20.35–20.10),
P = 0.0005; men, 20.19 kg change/(pmol/liter change) (CI,
20.41–0.03), P = 0.09).
As expected, we found an inverse age-adjusted association
between TSH change and free T4 change (P,0.0001, data not
shown). Regression coefficients of the three weight change tertiles
differed significantly in linear regression analysis of the association
between change in serum TSH concentration and free T4 change
(P,0.001) (Figure 2). The slope of the regression line was more
negative in persons in the upper weight change class (tertile), than
in the lower and middle tertiles. Serum TSH decreased by
20.150 mU/L (CI, 20.191, 20.109) and by 20.047 mU/L (CI,
20.096, 20.0018) for every one unit (pmol/liter) increase in free
T4, for persons with a weight change in the upper and lower
tertiles, respectively.
Among the 4,649 persons participating in the DanThyr baseline
study, 403 persons died and 72 emigrated before or during the 11-
year follow-up. Comparison of these persons with the survivors
who participated in the follow-up showed no difference between
the groups concerning baseline values of serum TSH concentra-
tions (P = 0.40), weight (P = 0.75), and BMI (P = 0.08), as
previously reported [24].
Discussion
In this community-based sample of 1,944 adults followed for 11
years, we found a statistically significant positive association
between change in serum TSH concentrations over time and
weight change. However, baseline TSH concentration was not a
determinant of change in weight and baseline BMI level was not a
determinant of change in TSH during follow-up. The relationship
between change in TSH and free T4 change differed significantly
between groups with different weight changes.
Several cross-sectional population studies found a significant
positive association between serum TSH levels and BMI or body
weight in individuals free of thyroid disease, in both sexes [13,16],
or in women only [15]. Also, in persons with TSH levels within the
normal reference range, a significant association with body weight
was confirmed [14,18], though restricted to non-smoking subjects
in one study [17]. Two studies could not confirm the association
[30,31]. Possible explanations for the lack of association found by
Manji et al. [31] could be the small sample size (N= 400), the
different clinical spectrum of the studied population (euthyroid
hospital-referred patients with thyroid nodules or goiter), and the
use of correlations without adjustment for confounders. Our result
regarding the significant, positive association between change in
serum TSH and change in body weight is in line with the results of
the four existing longitudinal population studies [14,17,19,20].
However, the association was restricted to women in the study by
Gopinath et al. [19] and to non-smokers in the Tromsø study [17].
Regarding the observed lack of association between baseline TSH
and weight change during follow-up, the same was observed by
Fox et al. [14] and Svare et al. [20]. Svare et al. [20], contrary to
our study, found a negative association between baseline BMI and
change in serum TSH. Fox et al. [14] and Nyrnes et al. [17] did
not investigate the association between baseline BMI and TSH
change.
Table 2. Multiple linear regression of the prospective association between 11-year change in body weight and change in serum
TSH in women and men.
Number Weight change per one-mU/L TSH increase
Modela kg (95% CI) Modelb kg (95% CI)
Individuals without thyroid disease Women 1,703 0.2 (0.05–0.4) 0.3 (0.1–0.4)
P = 0.01 P = 0.005
Men 399 0.8 (0.9–1.4) 0.8 (0.1–1.4)
P = 0.01 P = 0.02
Individuals without thyroid disease and euthyroid at
baseline
Women 1,577 0.6 (0.4–0.9) 0.6 (0.4, 0.9)
P,0.001 P,0.01
Men 367 0.8 (0.1–1.4) 0.7 (0.02–1.3)
P = 0.02 P = 0.04
CI confidence interval, TSH thyrotropin.
aUnadjusted model.
bModel adjusted for age, change in smoking and change in leisure time physical activity.
doi:10.1371/journal.pone.0093515.t002
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Fat tissue could affect thyroid hormones in a number of ways.
First, leptin, an adipocyte-derived hormone, could affect thyroid
hormone status through the stimulation of hypothalamic thyro-
tropin-releasing hormone (TRH) gene expression [32,33] and
influence thermogenesis [3]. However, as described in a recent
review, the role of leptin seems to be restricted to energy-deficient
states such as acute fasting and exercise, and evidence in humans is
still scarce [34]. Second, the effect may be due to a change in
deiodinase activity in central and/or peripheral tissue [2,9]. Third,
hormone resistance in obese subjects as a result of a T3 receptor
decrease has been suggested [33]. Fourth, a partially bioinactive
TSH protein in obese subjects has been speculated [33].
Our longitudinal results provide insight into the association
between body weight and TSH found in cross-sectional observa-
tional studies. An association between weight and serum TSH
seems to be present at all time points. However, the association we
found does not necessarily reflect a causal relationship. Both TSH
and weight might be modified by a third factor. The absence of a
predictive value of TSH for weight change and of BMI for TSH
change could suggest that this might be the case.
A modifying effect of tobacco smoking on the relationship
between thyroid function and BMI in euthyroid subjects has been
suggested [30]. Our analyses do not, however, support tobacco
smoking as a modifying factor, as we found no significant
interaction with change in smoking status in any of the models.
Previous studies of the TSH/free T4 relationship have shown
an exponential decrease in TSH with progressive increase in
serum T4 [35,36]. Ercan-Fang et al. suggested [21], in a study of
patients with hereditary pituitary resistance to thyroid hormones,
that assessment of the slope of lnTSH as a function of free T4 was
a useful measure of the abnormal thyroid hormone sensitivity. The
exact mechanism behind the observed difference in the DTSH/D
free T4-relation for the upper, middle and lower tertiles of weight
change, can not be resolved on the basis of this study. Possible
suggestions could however be a higher pituitary response to
change in free T4 with increasing weight, a less biological active
TSH molecule with increasing weight, or even more speculative,
that the thyroid glands response is less sensitive to TSH with
increasing weight.
Our cohort was exposed to a program of mandatory iodization
of salt, resulting in an increased iodine urine excretion [24]. It may
be speculated that the increased iodine intake could affect the
studied association. To the best of our knowledge, no studies have
described an association between iodine intake and weight, which
speaks against iodine as a possible confounder of the studied
associations. Moreover, the absence of interaction with region (as a
proxy for different levels of iodine intake) in the adjusted model of
weight change and TSH change and the fact that creatinine-
adjusted iodine excretion was not associated with change in weight
imply that the iodization program was unlikely to have had a
major effect on the studied association.
The strengths of our study are the longitudinal population-
based design, ensuring the temporality of studied associations; the
long-term follow-up; the objective measurement of exposures and
outcomes; the measurement of free T4 beside TSH at baseline and
follow-up; and the detailed information on covariates. The
limitations could be residual confounding from unmeasured
confounders such as diet or non-thyroidal illness; and selection
bias as a consequence of the relatively low participation rate of
59.1%. Furthermore, TSH is a measurement known to have a
large within individual variation and analytical variation [37], and
the fact that the determination of TSH relied on a single
measurement at baseline and at follow-up could bias the values of
change in TSH during follow-up. This would, however, only lead
to a nondifferential misclassification. Repeated measurements of
TSH and weight in each individual during the follow-up period
would more precisely outline the shape of their relationship with
time [38].
Figure 2. Unadjusted regression lines for weight change tertiles in women (n=1,577). 11-year weight change was divided in three groups,
a lower, middle and upper tertiles. In the adjusted regression model, regression coefficients (b) for the association between Dfree T4 and DTSH
differed significantly in the three groups (P,0.0007 for the interaction between Dfree T4 and Dweight tertiles), and was estimated to: blower D weight
tertile =20.047 mU/L (CI, 20.096, 20.0018), bmiddle D weight tertile =20.049 mU/L (CI, 20.093, 20.005), and bupper D weight tertile =20.150 mU/L (CI,
20.191, 20.109). Note the lines of the lower and middle weight change tertiles are difficult to distinguish from each other. Adjustments were made
for age group (categorical), change in smoking status, change in leisure time physical activity, and for the baseline value of the outcome.
doi:10.1371/journal.pone.0093515.g002
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Conclusion
In conclusion, TSH levels are not a determinant of future
weight changes and BMI is not a determinant of TSH changes,
but changes in TSH levels seems to be positively associated with
weight change. It remains to be proven whether body weight and
serum TSH are causally connected.
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